Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy

Joop A.M.J.L. Janssen*, Fanny M. van der Toorn, Leo J. Hofland, Peter van Koetsveld, Fabio Broglio, Ezio Ghigo, Steven W.J. Lamberts, Aart-Jan van der Lely

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

114 Citations (Scopus)
2 Downloads (Pure)

Abstract

We did not observe elevated ghrelin levels in adult GHD subjects and GH replacement therapy did not modify circulating ghrelin levels, despite significant decreases in body fat mass and percentage body fat. It is conceivable that the lack of ghrelin modifications after long-term GH therapy was due to the reduction of adiposity and insulin on one hand, and increased GH secretion on the other. However, it is still possible that systemic ghrelin is involved in the development of obesity, both in normal and GHD subjects.
Original languageEnglish
Pages (from-to)711-716
Number of pages6
JournalEuropean Journal of Endocrinology
Volume145
DOIs
Publication statusPublished - Dec 2001

Bibliographical note

© 2001 Society of the European Journal of Endocrinology

Research programs

  • EMC 02-01-38-01-01

Fingerprint

Dive into the research topics of 'Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy'. Together they form a unique fingerprint.

Cite this